SINGAPORE (Dec 14): Clearbridge Health (CBH), the healthcare firm which focuses on the delivery of precision medicine, boosts a capable team to lead its expansion across Asia, says Maybank KimEng.

See: Clearbridge Health to list on Catalist; seeking to raise $24.6 million

CBH is an early entrant in Asia metabolomics profiling, precision oncology testing and genetic-based screening tests. The company also provides a range of healthcare services, from primary preventive services to oncology diagnostic services.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook